Last updated on February 2018

Study of Pharmacodynamics of LIK066 in Overweight and Obese Women With Polycystic Ovary Syndrome


Brief description of study

The purpose of the study is to evaluate whether LIK066 can be developed for the treatment of polycystic ovary syndrome (PCOS) in overweight and obese women.

Clinical Study Identifier: NCT03152591

Contact Investigators or Research Sites near you

Start Over

Novartis Pharmaceuticals

Novartis Investigative Site
Baton Rouge, LA United States
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Springfield, MO United States
  Connect »